Michael Hecker

3.3k total citations · 1 hit paper
76 papers, 2.2k citations indexed

About

Michael Hecker is a scholar working on Pathology and Forensic Medicine, Molecular Biology and Immunology. According to data from OpenAlex, Michael Hecker has authored 76 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Pathology and Forensic Medicine, 26 papers in Molecular Biology and 19 papers in Immunology. Recurrent topics in Michael Hecker's work include Multiple Sclerosis Research Studies (43 papers), Peripheral Neuropathies and Disorders (12 papers) and Rheumatoid Arthritis Research and Therapies (10 papers). Michael Hecker is often cited by papers focused on Multiple Sclerosis Research Studies (43 papers), Peripheral Neuropathies and Disorders (12 papers) and Rheumatoid Arthritis Research and Therapies (10 papers). Michael Hecker collaborates with scholars based in Germany, Austria and United Kingdom. Michael Hecker's co-authors include Uwe K. Zettl, Reinhard Guthke, Susanne Toepfer, Eugene van Someren, Dirk Koczan, Brit Fitzner, Hans‐Jürgen Thiesen, Niklas Frahm, Brigitte Katrin Paap and Madhan Thamilarasan and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and PLoS ONE.

In The Last Decade

Michael Hecker

69 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Gene regulatory network inference: Data integration in dynamic models—A review

2008 511 citations Michael Hecker et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael Hecker Germany	27	1.2k	648	378	365	259	76	2.2k
Calliope A. Dendrou United Kingdom	15	872 0.8×	855 1.3×	1.3k 3.3×	153 0.4×	221 0.9×	32	2.9k
Daniel M. Jordan United States	14	1.8k 1.5×	227 0.4×	197 0.5×	401 1.1×	125 0.5×	36	3.3k
Eric W. Klee United States	34	2.1k 1.8×	236 0.4×	201 0.5×	652 1.8×	164 0.6×	178	4.0k
Hauke Busch Germany	34	2.0k 1.7×	448 0.7×	501 1.3×	731 2.0×	155 0.6×	181	3.8k
Piero Tosi Italy	33	1.1k 1.0×	857 1.3×	455 1.2×	342 0.9×	79 0.3×	97	3.1k
Heather P. McDowell United Kingdom	26	1.5k 1.3×	279 0.4×	397 1.1×	633 1.7×	106 0.4×	63	2.8k
Seunggeun Lee United States	25	1.9k 1.6×	167 0.3×	178 0.5×	249 0.7×	170 0.7×	81	4.6k
Chun‐Fang Xu United Kingdom	35	1.6k 1.4×	418 0.6×	307 0.8×	495 1.4×	76 0.3×	105	3.8k
Heather Junkins United States	8	3.6k 3.1×	233 0.4×	436 1.2×	782 2.1×	218 0.8×	10	6.2k
Jason M. Rosenzweig United States	19	1.7k 1.4×	174 0.3×	227 0.6×	293 0.8×	94 0.4×	25	2.8k

Countries citing papers authored by Michael Hecker

Since Specialization

Citations

This map shows the geographic impact of Michael Hecker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Hecker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Hecker more than expected).

Fields of papers citing papers by Michael Hecker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Hecker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Hecker. The network helps show where Michael Hecker may publish in the future.

Co-authorship network of co-authors of Michael Hecker

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Hecker. A scholar is included among the top collaborators of Michael Hecker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Hecker. Michael Hecker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hecker, Michael, et al.. (2025). Cost patterns of long-term prescribed medications in patients with multiple sclerosis in Germany. Scientific Reports. 15(1). 37363–37363.

Hecker, Michael, et al.. (2025). Trauma Burden Affected People with Multiple Sclerosis During SARS-CoV-2 Pandemic. Journal of Clinical Medicine. 14(8). 2665–2665.

Hofrichter, Jacqueline, Reinhold Wasserkort, Brit Fitzner, et al.. (2024). The Utility of Miniaturized Adsorbers in Exploring the Cellular and Molecular Effects of Blood Purification: A Pilot Study with a Focus on Immunoadsorption in Multiple Sclerosis. International Journal of Molecular Sciences. 25(5). 2590–2590.

Hecker, Michael, Brit Fitzner, Dirk Koczan, et al.. (2024). Differential gene expression in B cells and T helper cells following high-dose glucocorticoid therapy for multiple sclerosis relapse. Biomedicine & Pharmacotherapy. 175. 116721–116721. 1 indexed citations

Zettl, Uwe K., Niklas Frahm, & Michael Hecker. (2024). Challenges in monitoring the quality of care in multiple sclerosis. The Lancet Regional Health - Europe. 42. 100950–100950.

Frahm, Niklas, et al.. (2023). Depression and Anxiety in Association with Polypharmacy in Patients with Multiple Sclerosis. Journal of Clinical Medicine. 12(16). 5379–5379. 3 indexed citations

Hecker, Michael, Niklas Frahm, & Uwe K. Zettl. (2023). Update and Application of a Deep Learning Model for the Prediction of Interactions between Drugs Used by Patients with Multiple Sclerosis. Pharmaceutics. 16(1). 3–3. 5 indexed citations

Engelmann, Robby, Nadja Jaekel, Frank Bernhard Kraus, et al.. (2023). Vector-based SARS-CoV-2 vaccination is associated with improved T-cell responses in hematological neoplasia. Blood Advances. 7(14). 3403–3415. 1 indexed citations

Frahm, Niklas, et al.. (2022). Vaccination Coverage against Tetanus, Diphtheria, Pertussis and Poliomyelitis and Validity of Self-Reported Vaccination Status in Patients with Multiple Sclerosis. Journal of Personalized Medicine. 12(5). 677–677. 4 indexed citations

10.

Hecker, Michael, et al.. (2022). Screening for severe drug-drug interactions in patients with multiple sclerosis: A comparison of three drug interaction databases. Frontiers in Pharmacology. 13. 946351–946351. 15 indexed citations

11.

Frahm, Niklas, Michael Hecker, & Uwe K. Zettl. (2021). Polypharmacy in Chronic Neurological Diseases: Multiple Sclerosis, Dementia and Parkinson’s Disease. Current Pharmaceutical Design. 27(38). 4008–4016. 12 indexed citations

12.

Frahm, Niklas, et al.. (2020). The risk of polypharmacy, comorbidities and drug–drug interactions in women of childbearing age with multiple sclerosis. Therapeutic Advances in Neurological Disorders. 13. 1279191069–1279191069. 11 indexed citations

13.

Frahm, Niklas, Michael Hecker, & Uwe K. Zettl. (2020). Polypharmacy among patients with multiple sclerosis: a qualitative systematic review. Expert Opinion on Drug Safety. 19(2). 139–145. 37 indexed citations

14.

Frahm, Niklas, Michael Hecker, & Uwe K. Zettl. (2019). Polypharmacy in outpatients with relapsing-remitting multiple sclerosis: A single-center study. PLoS ONE. 14(1). e0211120–e0211120. 17 indexed citations

15.

Frahm, Niklas, Michael Hecker, & Uwe K. Zettl. (2019). Multi-drug use among patients with multiple sclerosis: A cross-sectional study of associations to clinicodemographic factors. Scientific Reports. 9(1). 3743–3743. 28 indexed citations

16.

Frahm, Niklas, Michael Hecker, & Uwe K. Zettl. (2019). Polypharmacy in patients with multiple sclerosis: a gender-specific analysis. Biology of Sex Differences. 10(1). 27–27. 19 indexed citations

17.

Hecker, Michael, Dirk Koczan, Brit Fitzner, et al.. (2018). Transcriptome profiling of peripheral blood immune cell populations in multiple sclerosis patients before and during treatment with a sphingosine‐1‐phosphate receptor modulator. CNS Neuroscience & Therapeutics. 24(3). 193–201. 19 indexed citations

18.

Koczan, Dirk, Brit Fitzner, Uwe K. Zettl, & Michael Hecker. (2018). Microarray data of transcriptome shifts in blood cell subsets during S1P receptor modulator therapy. Scientific Data. 5(1). 180145–180145. 14 indexed citations

19.

Winkelmann, Alexander, Paulus Rommer, Michael Hecker, & Uwe K. Zettl. (2018). Intravenous immunoglobulin treatment in multiple sclerosis: A prospective, rater‐blinded analysis of relapse rates during pregnancy and the postnatal period. CNS Neuroscience & Therapeutics. 25(1). 78–85. 11 indexed citations

20.

Hecker, Michael, Dirk Koczan, Brit Fitzner, et al.. (2016). High-Resolution Expression Profiling of Peripheral Blood CD8+ Cells in Patients with Multiple Sclerosis Displays Fingolimod-Induced Immune Cell Redistribution. Molecular Neurobiology. 54(7). 5511–5525. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact